| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |